Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy

Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy

Purpose. Intravesical Bacillus Calmette-Guerin (BCG) immunotherapy is indicated for high-grade nonmuscle-invasive bladder cancer (NMIBC). The efficacy of BCG in patients with a history of previous pelvic radiotherapy (RT) may be diminished. We evaluated the outcomes of radical cystectomy for BCG-tr...

Full description

Bibliographic Details
Main Authors: Rao, Manoj V., Quek, Marcus L., Jayram, Gautam, Ellimoottil, Chandy, Sondej, Timothy, Hugen, Cory M., Flanigan, Robert C., Steinberg, Gary D.
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730135/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730135/

Similar Items